Highland Private Wealth Management’s AbbVie ABBV Stock Holding History

Highland Private Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,189	Closed	-$1.23M	–	2
2022 Q3	$1.23M	Buy	9,189 +11	+0.1%	+$1.58K	0.2%	50
2022 Q2	$1.41M	Buy	9,178 +1,854	+25%	+$283K	0.22%	44
2022 Q1	$1.19M	Buy	7,324 +575	+9%	+$83.5K	0.16%	51
2021 Q4	$914K	Buy	6,749 +32	+0.5%	+$3.78K	0.12%	63
2021 Q3	$725K	Buy	6,717 +435	+7%	+$49.7K	0.1%	74
2021 Q2	$707K	Buy	6,282 +64	+1%	+$7.21K	0.1%	70
2021 Q1	$673K	Sell	6,218 -329	-5%	-$35.2K	0.11%	71
2020 Q4	$701K	Buy	6,547 +393	+6%	+$37.8K	0.12%	63
2020 Q3	$539K	Buy	6,154 +487	+9%	+$45.8K	0.11%	69
2020 Q2	$556K	Buy	5,667 +869	+18%	+$76.5K	0.12%	62
2020 Q1	$365K	Sell	4,798 -27	-0.6%	-$2.3K	0.1%	75
2019 Q4	$428K	Buy	4,825 +1,644	+52%	+$136K	0.1%	73
2019 Q3	$241K	Sell	3,181 -1,226	-28%	-$84.1K	0.07%	96
2019 Q2	$321K	Sell	4,407 -13	-0.3%	-$1.02K	0.09%	81
2019 Q1	$356K	Sell	4,420 -104	-2%	-$8.51K	0.11%	72
2018 Q4	$417K	Buy	4,524 +344	+8%	+$30.3K	0.16%	59
2018 Q3	$395K	Sell	4,180 -259	-6%	-$24.6K	0.13%	63
2018 Q2	$411K	Buy	+4,439	New	+$434K	0.15%	59
2018 Q1	–	Sell	-2,836	Closed	-$274K	–	101
2017 Q4	$274K	Buy	2,836 +32	+1%	+$3.02K	0.11%	78
2017 Q3	$249K	Sell	2,804 -455	-14%	-$34.6K	0.11%	78
2017 Q2	$236K	Buy	3,259 +79	+2%	+$5.31K	0.11%	76
2017 Q1	$207K	Buy	+3,180	New	+$200K	0.11%	71
2016 Q4	–	Sell	-3,241	Closed	-$204K	–	80
2016 Q3	$204K	Sell	3,241 -121	-4%	-$7.83K	0.1%	73
2016 Q2	$207K	Buy	+3,362	New	+$205K	0.12%	71

Other funds holding ABBV

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Highland Private Wealth Management's ABBV Position: Q4 2022 in Review

Highland Private Wealth Management sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 9,189 shares — an estimated $1.23M sold.

Highland Private Wealth Management first reported a position in ABBV in Q2 2016 and held it in 24 quarters. The position peaked at $1.41M in Q2 2022. 3,168 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

Highland Private Wealth Management reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
Highland Private Wealth Management sold 9,189 AbbVie shares in Q4 2022, an estimated $1.23M.
Highland Private Wealth Management first reported a position in AbbVie in Q2 2016 and held it in 24 quarters.
Highland Private Wealth Management's AbbVie position peaked at $1.41M in Q2 2022.
3,168 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Highland Private Wealth Management's 13F filing for Q4 2022.